About Icons

Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

Recombinant human growth hormone + rosiglitazone
(D08491)

[1] Rosiglitazone

[2] Rosiglitazone maleate ,
Rosiglitazone (D08491) 💬

[1] PPARG 💬

[12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬

[1] 265 💬

2

Rosiglitazone
(D08491)

[1] Rosiglitazone

[2] Rosiglitazone maleate ,
Rosiglitazone (D08491) 💬

[1] PPARG 💬

[12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬

[7] 46, 57, 75, 77, 97, 222, 265 💬

Disease ID	Name
46	Malignant rheumatoid arthritis
57	Idiopathic dilated cardiomyopathy
75	Cushing disease
77	Growth hormone secreting pituitary adenoma
97	Ulcerative colitis
222	Primary nephrotic syndrome
265	Lipodystrophy

3

Rosiglitazone (Avandia)
(D08491)

[1] Rosiglitazone

[2] Rosiglitazone maleate ,
Rosiglitazone (D08491) 💬

[1] PPARG 💬

[12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬

[1] 222 💬

4

Rosiglitazone Extended Release Tablets
(D08491)

[1] Rosiglitazone

[2] Rosiglitazone maleate ,
Rosiglitazone (D08491) 💬

[1] PPARG 💬

[12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬

[1] 46 💬

5

Rosiglitazone maleate
(D08491)

[1] Rosiglitazone

[2] Rosiglitazone maleate ,
Rosiglitazone (D08491) 💬

[1] PPARG 💬

[12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬

[3] 46, 75, 265 💬

6

Rosiglitazone therapy
(D08491)

[1] Rosiglitazone

[2] Rosiglitazone maleate ,
Rosiglitazone (D08491) 💬

[1] PPARG 💬

[12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬

[1] 57 💬

7

Rosiglitazone XR
(D08491)

[1] Rosiglitazone

[2] Rosiglitazone maleate ,
Rosiglitazone (D08491) 💬

[1] PPARG 💬

[12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬

[1] 46 💬